rabbit polyclonal anti phospho eef2 (Bioss)
Structured Review
Rabbit Polyclonal Anti Phospho Eef2, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+phospho+eef2/EEF2+(Thr56+%2B+Thr58)+Polyclonal+Antibody/pm41619002-51-15-22
Average 94 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Buparlisib induces eukaryotic elongation factor-2 expression to cause treatment failure for lung cancer cells. Article Snippet: 1 Department of Oncology, Xianyang Central Hospital, No. 78, Renmin East Road, Weicheng District, Xianyang 712000, Shaanxi Province, China 2 Clinical Medicine College, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China 3 Key laboratory of the Jiangsu Higher Education Institutions for Integrated Traditional Chinese and Western Medicine in Senile Diseases Control, Faculty of Medicine, Yangzhou University, No.88, South University Road, Yangzhou 225001, Jiangsu Province, China Abstract Background The phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway is closely associated with the development and progression of lung cancer.. Buparlisib (BKM-120), a selective PI3K inhibitor, represents a novel potential therapeutic strategy for lung cancer.. However, the reason for its limited initial efficacy as a monotherapy remains poorly understood. |




